Brian Abrahams
Stock Analyst at RBC Capital
(1.53)
# 3,275
Out of 4,876 analysts
457
Total ratings
39.33%
Success rate
-10.34%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintains: Outperform | $205 → $213 | $126.92 | +67.82% | 37 | Jun 25, 2025 | |
| CDTX Cidara Therapeutics | Maintains: Outperform | $35 → $75 | $48.03 | +56.15% | 1 | Jun 24, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Outperform | $26 → $38 | $22.21 | +71.09% | 1 | Jun 23, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Sector Perform | $423 → $420 | $443.40 | -5.28% | 53 | Jun 17, 2025 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Outperform | $67 | $47.29 | +41.68% | 2 | Jun 3, 2025 | |
| NBIX Neurocrine Biosciences | Reiterates: Outperform | $145 | $126.71 | +14.43% | 20 | Jun 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Outperform | $943 | $521.00 | +81.00% | 32 | May 27, 2025 | |
| CTNM Contineum Therapeutics | Reiterates: Outperform | $31 | $4.01 | +673.07% | 5 | May 15, 2025 | |
| AARD Aardvark Therapeutics | Maintains: Outperform | $21 → $20 | $13.86 | +44.30% | 3 | May 15, 2025 | |
| APLT Applied Therapeutics | Reiterates: Sector Perform | $1.5 | $0.38 | +294.74% | 6 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $33 | $4.49 | +634.97% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $55 | $32.20 | +70.81% | 14 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $87 → $58 | $17.23 | +236.62% | 34 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $57 → $58 | $49.55 | +17.05% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $58 | $8.02 | +623.19% | 8 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $11 → $13 | $9.66 | +34.58% | 18 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $64 → $67 | $70.81 | -5.38% | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $33.48 | +150.90% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $12.40 | +150.00% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.30 | +130.77% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $0.80 | +400.38% | 6 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $20 | $6.18 | +223.62% | 10 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $84 → $90 | $107.62 | -16.37% | 31 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $102.57 | +39.42% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $18.45 | +116.80% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $20 → $1.5 | $1.22 | +22.95% | 15 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $48 → $2 | $1.25 | +60.00% | 11 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Perform | $4 | $9.28 | -56.90% | 21 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $32 → $30 | $28.07 | +6.88% | 11 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $13 → $12 | $9.95 | +20.60% | 14 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $6.74 | +226.41% | 9 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $7.51 | +99.73% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $2.25 | +300.00% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $33 | $53.18 | -37.95% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $37.13 | - | 4 | Dec 4, 2017 |
Biogen
Jun 25, 2025
Maintains: Outperform
Price Target: $205 → $213
Current: $126.92
Upside: +67.82%
Cidara Therapeutics
Jun 24, 2025
Maintains: Outperform
Price Target: $35 → $75
Current: $48.03
Upside: +56.15%
ACADIA Pharmaceuticals
Jun 23, 2025
Maintains: Outperform
Price Target: $26 → $38
Current: $22.21
Upside: +71.09%
Vertex Pharmaceuticals
Jun 17, 2025
Maintains: Sector Perform
Price Target: $423 → $420
Current: $443.40
Upside: -5.28%
MoonLake Immunotherapeutics
Jun 3, 2025
Reiterates: Outperform
Price Target: $67
Current: $47.29
Upside: +41.68%
Neurocrine Biosciences
Jun 2, 2025
Reiterates: Outperform
Price Target: $145
Current: $126.71
Upside: +14.43%
Regeneron Pharmaceuticals
May 27, 2025
Reiterates: Outperform
Price Target: $943
Current: $521.00
Upside: +81.00%
Contineum Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $31
Current: $4.01
Upside: +673.07%
Aardvark Therapeutics
May 15, 2025
Maintains: Outperform
Price Target: $21 → $20
Current: $13.86
Upside: +44.30%
Applied Therapeutics
May 14, 2025
Reiterates: Sector Perform
Price Target: $1.5
Current: $0.38
Upside: +294.74%
May 13, 2025
Maintains: Outperform
Price Target: $34 → $33
Current: $4.49
Upside: +634.97%
May 13, 2025
Maintains: Outperform
Price Target: $58 → $55
Current: $32.20
Upside: +70.81%
May 7, 2025
Maintains: Sector Perform
Price Target: $87 → $58
Current: $17.23
Upside: +236.62%
May 7, 2025
Maintains: Outperform
Price Target: $57 → $58
Current: $49.55
Upside: +17.05%
May 7, 2025
Maintains: Outperform
Price Target: $65 → $58
Current: $8.02
Upside: +623.19%
May 6, 2025
Reiterates: Outperform
Price Target: $11 → $13
Current: $9.66
Upside: +34.58%
Apr 30, 2025
Maintains: Sector Perform
Price Target: $64 → $67
Current: $70.81
Upside: -5.38%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $33.48
Upside: +150.90%
Mar 7, 2025
Initiates: Outperform
Price Target: $31
Current: $12.40
Upside: +150.00%
Mar 4, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.30
Upside: +130.77%
Mar 4, 2025
Reiterates: Sector Perform
Price Target: $4
Current: $0.80
Upside: +400.38%
Feb 21, 2025
Maintains: Sector Perform
Price Target: $24 → $20
Current: $6.18
Upside: +223.62%
Feb 12, 2025
Maintains: Sector Perform
Price Target: $84 → $90
Current: $107.62
Upside: -16.37%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $102.57
Upside: +39.42%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $18.45
Upside: +116.80%
Jan 10, 2025
Downgrades: Sector Perform
Price Target: $20 → $1.5
Current: $1.22
Upside: +22.95%
Dec 20, 2024
Downgrades: Sector Perform
Price Target: $48 → $2
Current: $1.25
Upside: +60.00%
Nov 21, 2024
Upgrades: Sector Perform
Price Target: $4
Current: $9.28
Upside: -56.90%
Nov 1, 2024
Maintains: Sector Perform
Price Target: $32 → $30
Current: $28.07
Upside: +6.88%
Aug 6, 2024
Maintains: Sector Perform
Price Target: $13 → $12
Current: $9.95
Upside: +20.60%
Jun 5, 2024
Reiterates: Outperform
Price Target: $22
Current: $6.74
Upside: +226.41%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $7.51
Upside: +99.73%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $2.25
Upside: +300.00%
Nov 3, 2021
Maintains: Sector Perform
Price Target: $21 → $33
Current: $53.18
Upside: -37.95%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $37.13
Upside: -